Global Lupus Nephritis Market: Industry Analysis & Outlook (2021-2030)

1
Industry Research by Koncept Analytics
Global Lupus Nephritis Market Industry Analysis
Outlook ---------------------------------------
-- (2021-2030)
May 2017
2
Executive Summary
Lupus nephritis is inflammation of the kidney
that is caused by systemic lupus erythematous
(SLE). Also called lupus, SLE is an autoimmune
disease where the immune system turns against the
body, affecting vital organs. While the primary
cause of the disease is unknown, it is expected
that factors such as viruses, infections,
pollutants, and toxic chemicals, along with
family history plays a role in causing the
disease. The disease is more common in women
compared to men. Kidney damage from lupus
erythematosus can vary from mild to severe. In
lupus nephritis, glomeruli or the filtering units
are damaged. As a result, waste from the blood
does not get filtered. Lupus nephritis happens
when lupus involves the kidneys. When the kidneys
are inflamed, they cannot function normally and
can leak protein. If not controlled, lupus
nephritis can lead to kidney failure. The
treatment for Lupus Nephritis is based upon on
its type, which is determined by the biopsy.
Since, symptoms and severity vary from person to
person, treatments are individually tailored to
meet a person's particular circumstances. The
global Lupus Nephritis market is set to
experience favourable growth driven by factors
such as increasing African-American population,
rising health care expenditure and accelerating
economic growth. The major trends observed in the
market are new drugs under pipeline for Lupus
Nephritis, increasing research grants with rising
public awareness about the disease. However, the
growth of this budding market will be hindered by
stringent regulations, associated risk and high
cost. The report Global Lupus Nephritis Market
Industry Analysis Outlook (2021-2030) analyses
the development of this market, with focus on the
U.S, Europe and Japan markets. The major trends,
growth drivers as well as issues being faced by
the market are discussed in detail in this
report. The five major players Aurinia
Pharmaceuticals Inc., Roche Holding AG,
Bristol-Myers Squibb, GlaxoSmithKline Plc. and
AstraZeneca are being profiled along with their
key financials and strategies for growth. The
report contains a comprehensive analysis of the
global Lupus Nephritis market along with the
study of the regional markets.
3
Rising African-American population and increasing
health care expenditure supported the growth of
lupus nephritis market.
Global Lupus Nephritis Market Forecast by Value
(2021-2030)

• The global lupus nephritis market is estimated
  to reach US ..million by the year 2021, and
  would reach US ..million by year 2030, recording
  growth at a CAGR of .. for the period spanning
  2021-2030.
• The global lupus nephritis patient population is
  anticipated to reach ..thousand by the year 2030,
  increasing from ..thousand in the year 2021,
  recording growth at a CAGR of .. for the period
  spanning 2021-2030.
• It is expected that by the year 2022, the U.S.
  would hold the largest market share of ..
  followed by Japan and Europe with .. shares
  respectively.

Global Lupus Nephritis Market by Region
(2021/2030)
Global Lupus Nephritis Patient Population
Forecast (2021-2030)
2030
2022
4
Accelerating economic growth and development
of new biological drugs will drive the market for
lupus nephritis globally..
The U.S. Lupus Nephritis Market Forecast by
Value (2021-2030)

• The U.S. lupus nephritis market is expected to
  reach US ..million by the year 2021, and would
  reach US ..million by year 2030, recording
  growth at a CAGR of .. for the period spanning
  2021-2030.
• The U.S. lupus nephritis patient population is
  anticipated to reach ..thousand by the year 2030,
  increasing from ..thousand in the year 2021. The
  patient population is expected to grow at a CAGR
  of .. for the period spanning 2021-2030.
• In Japan, lupus nephritis market is expected to
  reach US ..million by the year 2022, and is
  further anticipated to reach US ..million by
  year 2030, recording growth at a CAGR of .. for
  the period spanning 2022-2030.

Japan Lupus Nephritis Market Forecast by
Value (2022-2030)
T The U.S. Lupus Nephritis Patient Population
Forecast (2021-2030)
5
Disclaimer
Contact Us
This is a licensed product of Koncept Analytics.
You cannot reproduce, publish, distribute,
publicly display, sell or create other works from
this report or use them in any way for commercial
purpose without our prior permission. Further,
you cannot copy this material, by any means
(including electronic copies), for distribution
to others unless you have purchased the corporate
license of this report. We believe the sources
are reliable, but Koncept Analytics does not
warranty the accuracy or completeness of the
data. The data presented in the report is updated
at the publication date but is subject to change
at subsequent releases. All possible efforts have
been made to ensure accuracy of data. However,
investors should not completely rely on the
information given in this report and must make
decisions based on their own investment strategy,
risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T
91-120-4130959 M 91-9811715635
vikas_at_konceptanalytics.com
www.konceptanalytics.com